Wells Fargo’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Wells Fargo’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-8,423	Closed	-$203K	–	6611
2014 Q2	$203K	Buy	8,423 +3,508	+71%	+$36.6K	﹤0.01%	4369
2014 Q1	$30K	Buy	+4,915	New	+$34.3K	﹤0.01%	5105
2013 Q3	–	Sell	-2,129	Closed	-$8K	–	6066
2013 Q2	$8K	Buy	+2,129	New	+$8.71K	﹤0.01%	5135

Wells Fargo's IDIX Position: Q3 2014 in Review

Wells Fargo sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 8,423 shares — an estimated $203K sold.

Wells Fargo first reported a position in IDIX in Q2 2013 and held it in 3 quarters. The position peaked at $203K in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Wells Fargo reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Wells Fargo sold 8,423 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $203K.
Wells Fargo first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 3 quarters.
Wells Fargo's IDENIX PHARMACEUTICALS INC position peaked at $203K in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Wells Fargo's 13F filing for Q3 2014, filed 6 Nov 2014.